Literature DB >> 25810392

A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections.

Curtis J Pritzl1, Young-Jin Seo1, Chuan Xia1, Madhuvanthi Vijayan1, Zachary D Stokes1, Bumsuk Hahm2.   

Abstract

The ceramide family of lipids plays important roles in both cell structure and signaling in a diverse array of cell types, including immune cells. However, very little is known regarding how ceramide affects the activation of dendritic cells (DCs) in response to viral infection. In this study, we demonstrate that a synthetic ceramide analog (C8) stimulates DCs to increase the expansion of virus-specific T cells upon virus infection. Exogenously supplied C8 ceramide elevated the expression of DC maturation markers such as MHC class I and costimulatory molecules following infection with the clone 13 strain of lymphocytic choriomeningitis virus (LCMV) or influenza virus. Importantly, ceramide-conditioned, LCMV-infected DCs displayed an increased ability to promote expansion of virus-specific CD8(+) T cells when compared with virus-infected DCs. Furthermore, a locally instilled ceramide analog significantly increased virus-reactive T cell responses in vivo to both LCMV and influenza virus infections. Collectively, these findings provide new insights into ceramide-mediated regulation of DC responses against virus infection and help us establish a foundation for novel immune-stimulatory therapeutics.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25810392      PMCID: PMC4402267          DOI: 10.4049/jimmunol.1402672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Profiling changes triggered during maturation of dendritic cells: a lipidomic approach.

Authors:  Deolinda R Santinha; Diane R Marques; Elisabete A Maciel; Cláudia S O Simões; Susana Rosa; Bruno M Neves; Bárbara Macedo; Pedro Domingues; M Teresa Cruz; M Rosário M Domingues
Journal:  Anal Bioanal Chem       Date:  2012-03-09       Impact factor: 4.142

Review 2.  Decisions about dendritic cells: past, present, and future.

Authors:  Ralph M Steinman
Journal:  Annu Rev Immunol       Date:  2011-11-17       Impact factor: 28.527

3.  Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205.

Authors:  Ali Badiee; Nigel Davies; Kylie McDonald; Kristen Radford; Hiroaki Michiue; Derek Hart; Masato Kato
Journal:  Vaccine       Date:  2007-05-02       Impact factor: 3.641

4.  Cross-presenting CD103+ dendritic cells are protected from influenza virus infection.

Authors:  Julie Helft; Balaji Manicassamy; Pierre Guermonprez; Daigo Hashimoto; Aymeric Silvin; Judith Agudo; Brian D Brown; Mirco Schmolke; Jennifer C Miller; Marylene Leboeuf; Kenneth M Murphy; Adolfo García-Sastre; Miriam Merad
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

5.  Ceramide induces apoptosis via caspase-dependent and caspase-independent pathways in mesenchymal stem cells derived from human adipose tissue.

Authors:  Ji Yeon Park; Moon Jung Kim; Yong Keun Kim; Jae Suk Woo
Journal:  Arch Toxicol       Date:  2011-01-23       Impact factor: 5.153

Review 6.  The role of dendritic cells in viral persistence.

Authors:  Cherie T Ng; Brian M Sullivan; Michael B A Oldstone
Journal:  Curr Opin Virol       Date:  2011-09       Impact factor: 7.090

7.  Sphingosine analogue AAL-R increases TLR7-mediated dendritic cell responses via p38 and type I IFN signaling pathways.

Authors:  Young-Jin Seo; Curtis J Pritzl; Madhuvanthi Vijayan; Celeste R Blake; Mariah E McClain; Bumsuk Hahm
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

8.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

9.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

Authors:  E John Wherry; Sang-Jun Ha; Susan M Kaech; W Nicholas Haining; Surojit Sarkar; Vandana Kalia; Shruti Subramaniam; Joseph N Blattman; Daniel L Barber; Rafi Ahmed
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

10.  Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.

Authors:  Norika Chiba; Akio Masuda; Yasunobu Yoshikai; Tetsuya Matsuguchi
Journal:  J Cell Physiol       Date:  2007-10       Impact factor: 6.384

View more
  15 in total

1.  NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality.

Authors:  Karin M Knudson; Curtis J Pritzl; Vikas Saxena; Amnon Altman; Mark A Daniels; Emma Teixeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Transient inhibition of sphingosine kinases confers protection to influenza A virus infected mice.

Authors:  Chuan Xia; Young-Jin Seo; Caleb J Studstill; Madhuvanthi Vijayan; Jennifer J Wolf; Bumsuk Hahm
Journal:  Antiviral Res       Date:  2018-08-17       Impact factor: 5.970

3.  Ceramide Suppresses Influenza A Virus Replication In Vitro.

Authors:  Nadia Soudani; Rouba Hage-Sleiman; Walid Karam; Ghassan Dbaibo; Hassan Zaraket
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.

Authors:  Chuan Xia; Madhuvanthi Vijayan; Curtis J Pritzl; Serge Y Fuchs; Adrian B McDermott; Bumsuk Hahm
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

5.  Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence.

Authors:  Caleb J Studstill; Curtis J Pritzl; Young-Jin Seo; Dae Young Kim; Chuan Xia; Jennifer J Wolf; Ravi Nistala; Madhuvanthi Vijayan; Yong-Bin Cho; Kyung Won Kang; Sang-Myeong Lee; Bumsuk Hahm
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

6.  Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.

Authors:  Chuan Xia; Jennifer J Wolf; Madhuvanthi Vijayan; Caleb J Studstill; Wenjun Ma; Bumsuk Hahm
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

7.  Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.

Authors:  Guangfu Li; Dai Liu; Eric T Kimchi; Jussuf T Kaifi; Xiaoqiang Qi; Yariswamy Manjunath; Xinjian Liu; Tye Deering; Diego M Avella; Todd Fox; Don C Rockey; Todd D Schell; Mark Kester; Kevin F Staveley-O'Carroll
Journal:  Gastroenterology       Date:  2018-01-31       Impact factor: 22.682

Review 8.  Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis.

Authors:  Katarzyna Bocheńska; Magdalena Gabig-Cimińska
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

9.  Depletion of Host and Viral Sphingomyelin Impairs Influenza Virus Infection.

Authors:  Amani Audi; Nadia Soudani; Ghassan Dbaibo; Hassan Zaraket
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

10.  Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.

Authors:  Dan Zhao; Laela M Hajiaghamohseni; Xiang Liu; Zdzislaw M Szulc; Aiping Bai; Alicja Bielawska; James S Norris; Sakamuri V Reddy; Yusuf A Hannun; Azizul Haque
Journal:  Cytokine       Date:  2020-07-29       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.